@kok_wai1985. You're right. A better result is expected in the last quarter of the year. The only thing worth to mention is the current quarter result won't impact much on its price, as this is definitely NOT the reason why the price moved up steadily throughout the month, especially with such a huge volume traded yesterday.
@ginduchti Hi , I think you are pretty right , but sometimes the sentiment is here , and you never know if they will release some news ( solid or not doesn’t matter )
the bosses knew qtr result bad yet share price starts to move higher with large vol there must be something happening that we dont know , bright future ...fly ...
CGS-CIMB has lowered its target price (TP) for Bioalpha to 28 sen as it believes the recovery in earnings going forward has largely been priced in at current valuations.
when investment house make tp, this is where it going to make worst to share price. all investment house simply tembak tp don't know whether they know the real cheese behind or not.
This translates to a potential contract value of up to RMB3.5 billion or RM2.1 billion over a 5-year period. - with this news TP can go up to rm1.00 so better keep for one year - my 0.315 point
Nice to know most comments here is positive and long term holder, unlike other counters where you can see all sorts of comments. If you think can time the market based on QR, news or rumors then wish you all the best.
I think there are many observers here who never comment will agree that staying put is usually the best course of action. Hence we have the 80/20 or 90/10 throughout the ages, that this is the human condition which keeps the market alive.
if u see some other share like ... prlexus .. mieco ... evergreen ... previously qr loss making also quietly go up .. strange share price movement ... then only latest qr show why .. All because future profit turnaround ... many insiders already knew their future Biz turnaround and push the price up even though previous qr was loss making ...
Hold firm as the pp by the management teams are securing the funds to further strengthen their health products via collaboration with China to maximise in health care products. Next qr will fare better as the losses is a one off losses to pare down indebtedness and the previous slow sales performance.
Accept the bad QR. Is real, but all the sifu comment on tis company say how good is it remember anything can happen if the bad new say china contract can terminate anytime with certain reason, dont trust too much on china company. Got profit just take.
Bioalpha's China contracts expected to drive significant improvement in coming quarters TheEdge Sat, Nov 28, 2020 02:00pm - 20 hours ago
KUALA LUMPUR (Nov 28): Integrated health supplement company Bioalpha Holdings Bhd’s contracts with China parties, namely Guizhou Yuhexin Trading Ltd and Hainan Shifengfu Co Ltd, are expected to drive a significant improvement in the upcoming quarters after ravages by Covid-19.
“We expect the gradual commencement of the new China contracts in the upcoming quarters to drive a significant improvement going forward,” CGS-CIMB Securities said today.
Recently this year, Bioalpha entered into two agreements with Guizhou Yuhexin and Hainan Shifengfu, valued at 700 million yuan (RM426.7 million) annually for a duration of five years.
The partnership commenced in September 2020 with Bioalpha supplying health and nutritional goods to Guizhou Yuhexin to be sold mainly in the Guizhou province of China.
“Our recent channel checks with Bioalpha indicated that effective gross profit margins for the contracts are 3%-5%,” CGS-CIMB said in a research note here today.
Bioalpha’s core net loss came in at RM7.1 million for the third quarter ended Sept 30, 2020 (3QFY20), against a net profit of RM2.5 million for 3QFY19, after adding back a one-off loss of RM4.2 million (write-offs of inventories and bad debts, and impairment of trade receivables and goodwill).
The disappointing 3QFY20 results were due to weaker-than-expected export sales and a surge in operating cost.
On a quarter-on-quarter (q-o-q) basis, 3QFY20 revenue rose by 7.5%, but core net loss widened by 8.9% mainly due to weaker-than-expected export sales and a surge in operating cost.
CGS-CIMB has lowered its target price (TP) for Bioalpha to 28 sen as it believes the recovery in earnings going forward has largely been priced in at current valuations.
MENTIGA 0.580 +0.14 (+31.8%) Quarterly rpt on consolidated results for the financial period ended 30 Sep 2020 MENTIGA CORPORATION BERHAD
Financial Year End 31 Dec 2020 Quarter 3 Qtr Quarterly report for the financial period ended 30 Sep 2020 The figures have not been audited Attachments Q320 for announcement.pdf 110.9 kBQ320 notes to the account.pdf 221.4 kB Default CurrencyOther Currency Currency: Malaysian Ringgit (MYR)
SUMMARY OF KEY FINANCIAL INFORMATION 30 Sep 2020
INDIVIDUAL PERIOD CUMULATIVE PERIOD CURRENT YEAR QUARTER PRECEDING YEAR CORRESPONDING QUARTER CURRENT YEAR TO DATE PRECEDING YEAR CORRESPONDING PERIOD 30 Sep 2020 30 Sep 2019 30 Sep 2020 30 Sep 2019 $'000 $'000 $'000 $'000 1 Revenue 11,016 1,326 13,315 3,588 2 Profit/(loss) before tax 7,856 -2,080 2,525 -5,424 3 Profit/(loss) for the period 7,855 -2,081 2,522 -5,427 4 Profit/(loss) attributable to ordinary equity holders of the parent 7,855 -2,081 2,522 -5,427 5 Basic earnings/(loss) per share (Subunit) 10.94 -2.90 3.51 -7.56 6 Proposed/Declared dividend per share (Subunit) 0.00 0.00 0.00 0.00
AS AT END OF CURRENT QUARTER AS AT PRECEDING FINANCIAL YEAR END 7 Net assets per share attributable to ordinary equity holders of the parent ($) 2.6200 2.5900
Definition of Subunit: In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit. Example for the subunit as follows:
Country Base Unit Subunit Malaysia Ringgit Sen United States Dollar Cent United Kingdom Pound Pence
Announcement Info Company Name MENTIGA CORPORATION BERHAD Stock Name MENTIGA Date Announced 27 Nov 2020 Category Financial Results Reference Number FRA-26112020-00082
I’m looking forward to their businesses with China first through Guizhou Yuhexin Trading Ltd n HainanShifengfu Co. Ltd before I make any decision to sell. If the business with the two companies gives good results then I’ll continue to invest in it for long term.
Agree on good prospect Noted also there is a impairment loss in qtr that cause huge loss in this qtr So this impairment will not repeat in next qtr Cheers Future prospect is good
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
kok_wai1985
460 posts
Posted by kok_wai1985 > 2020-11-28 07:17 | Report Abuse
China contract start delivery in end of September 2020. Which mean the good result will happen in 4th quarter 2020. Not in 3rd quarter 2020. https://www.nst.com.my/business/2020/10/630726/bioalphas-health-food-ingredients-track-growth-china